2013
|
Invention
|
Lna antisense oligonucleotides for the modulation of myc expression. The disclosure relates to ol... |
2012
|
Invention
|
Rna antagonist compounds for the modulation of her3.
The invention relates to oligomer compounds... |
2011
|
Invention
|
Methods of treating cancers with her3 and pik3ca antisense oligonucleotides. One aspect of the in... |
|
Invention
|
Compositions and methods for treating androgen receptor dependent disorders including cancers. Th... |
|
Invention
|
Compounds for the modulation of beta-catenin expression.
The invention relates to oligomer compo... |
|
Invention
|
Polymeric conjugates of adenine nucleoside analogs. The present invention relates to polymeric co... |
2010
|
Invention
|
Polymeric conjugates of aromatic amine containing compounds including releasable urea linker. The... |
|
Invention
|
Rna antagonists targeting hsp27 combination therapy. The present invention relates to antisense o... |
|
Invention
|
Compounds for the modulation of beta-catenin expression. The invention relates to oligomer compou... |
|
Invention
|
Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-... |
|
Invention
|
Oligomeric compounds for the modulation of survivin expression. Oligonucleotides directed against... |
|
Invention
|
Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamp... |
|
Invention
|
Methods of treating cancers with her3 antisense oligonucleotides.
One aspect of the invention pr... |
|
Invention
|
Methods of treating cancers with her3 antisense oligonucleotides. One aspect of the invention pro... |
|
Invention
|
Short rna antagonist compounds for the modulation of hif-1alpha.
The present invention relates t... |
|
Invention
|
Rna antagonists targeting gli2 for the treatment of leukemia. The present invention relates to ol... |
2009
|
Invention
|
Releasable conjugates for nucleic acids delivery systems. The present invention is directed to nu... |
|
Invention
|
Releasable cationic lipids for nucleic acids delivery systems. The present invention is directed ... |
|
Invention
|
Releasable fusogenic lipids for nucleic acids delivery systems. The present invention relates to ... |
|
Invention
|
Releasable polymeric lipids for nucleic acids delivery system. The present invention relates to p... |
|
Invention
|
Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugate... |
|
Invention
|
Erbb-3 (her3)-selective combination therapy.
The invention relates to pharmaceutical composition... |
|
Invention
|
Erbb-3 (her3)-selective combination therapy. The invention relates to pharmaceutical compositions... |
|
Invention
|
Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin.... |
|
Invention
|
Method of treating ras associated cancer. New methods of treating Ras associated cancer, and espe... |
|
Invention
|
Method of treating ras associated cancer.
New methods of treating Ras associated cancer, and esp... |
|
Invention
|
Branched cationic lipids for nucleic acids delivery system. The present invention is directed to ... |
|
Invention
|
Nanoparticle compositions for nucleic acids delivery system. The present invention is directed to... |
|
Invention
|
Rna antagonists targeting gli2. The present invention relates to oligomer compounds (oligomers), ... |
|
Invention
|
Rna antagonists targeting hsp27. The present invention relates to oligomer compounds (oligomers),... |
|
Invention
|
Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligon... |
2008
|
Invention
|
Rna antagonist compounds for the modulation of pik3ca expression. The invention relates to oligom... |
|
Invention
|
Rna antagonist compounds for the modulation of pik3ca expression. The present invention relates t... |
|
Invention
|
Lna antagonists targeting the androgen receptor. The present invention relates to oligomer compou... |
|
Invention
|
Prodrugs of vancomycin with hydrolysis resistant polymer linkages.
Vancomycin-polymer conjugates... |
|
Invention
|
Lna oligonucleotides and the treatment of cancer. xc-3′, wherein capital letters designate an LNA... |
|
Invention
|
Short rna antagonist compounds for the modulation of hif1alpha. The present invention relates to ... |
|
Invention
|
Polymeric drug delivery system containing a multi-substituted aromatic moiety. The present invent... |
|
Invention
|
Polymeric drug delivery systems containing an aromatic allylic acid. The present invention provid... |
|
Invention
|
Rna antagonist compounds for the modulation of her3. The invention relates to oligomer compounds ... |
2007
|
Invention
|
Polymeric linkers containing pyridyl disulfide moieties. The present invention provides polymeric... |
|
Invention
|
Indenoisoquinoline-releasable polymer conjugates.
The present invention provides releasably-link... |
|
P/S
|
Pharmaceutical research and development including treatment of biologically active materials such... |